1Higa GM,Alkhouri N.Anastroxole:a Selective aromatase inhibitor for the treatment of breast Cancer.AM J Health Syst pharm,1998,5(5):445~452.
2Jaiyesimi IA,Buxdar AU,Decker DA,et al.Use of tamoxifen for breast cancer:twenty-eight year later.J Clin Oncol,2001,15(2):513~529.
3Marty M,Gershanovich M,Campos B,et al,letrozole:a new potent,Selective aromatase inhibitor Superior to AG in postmenopausal women with advanced breast Cancer previously treated with anti-estrogens.Proc Am Soc clin Oncol,1999,16:544a.
4Gale KE,Andersen JW,Tormey DC,et al.Hormonal treatment for metastatic breast Cancer.An Eastern cooperative Oncology Group phase Ⅲ trial comparing AG to TAM.Cancer,1999,73(2):345~361.
5Dixon JM,Love CDB,Tucker S,et al.Letrozole as primary medical therapy for locally advanced and large operable breast cancer.Proc ASCO,1998,17:104.
7Lupulescu A.Estrogen use and cancer incidence:a review.Cancer Invest.1995,13(3):287.
8Saunders P,Millar M,Williams K,et al.Expression of estrogen receptor beta (ERbetal) protein in human breast cancer biopsies.Br J Cancer.2002,86(2):250.
10Ismail PM,Amato P,Soyal SM,et al.Progesterone involvement in breast development and tumorgenesis as revealed by progesterone receptor "knock out" and "knock in" mouse models.Steroids.2003,68(10~13):779.